Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Isafjordur, ISL
Eyrargata 2
400 Isafjordur
Isafjordur, ISL

People

Co-Founder and Chairman of the Board
Co-Founder and Medical Director
Co-Founder and VP Medical Sciences
Co-Founder and Patent Counsel
Director
Director

Funding

TOTAL $4M
FUNDING TOTAL $4M
Seed, 1/2010
NSA Ventures
Series A, 5/2011
$1M
Series A, 4/2013
$1M
Series A, 2/2014
NSA Ventures
$2M

Competitors

Tags

Kerecis

Kerecis is developing the MariGen™ Omega3 acellular dermal matrix technology for use in products to treat chronic wounds, for hernia repair, breast reconstruction and abdominal wall reconstruction. Our patent pending acellular fish skin derived material improves upon current human and porcine technologies through improved economics and clinical performance, reduced disease transfer risk and absence of cultural constraints on usage.

Recent Milestones

Videos

Screenshots

Sources

  1. Kerecis Closes Start-Up Financing Round With the New Business Venture Fund (fiercebiotech.com) [edit]
  2. Kerecis Completes Interim Financing (marketwire.com) [edit]
  3. Kerecis Raises US$1M in Series A2 Funding (finsmes.com) [edit]
  4. Fish-Skin Medical Company Completes Funding Round (marketwired.com) [edit]
  5. Marketwire (marketwire.com) [edit]
    Marketwire (marketwire.com) [edit]
Edit This Page
Last Edited 2/21/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy